Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Lugli

Showing results (121-130 of 184) with videos related to

Pageof 19
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
EphB2 expression across 138 human tumor types in a tissue microarray: high levels of expression in gastrointestinal cancersAlessandro Lugli, Hanspeter Spichtin, Robert Maurer, et al.
Journal of Translational Medicine|March 5, 2013
The additional facet of immunoscore: immunoprofiling as a possible predictive tool for cancer treatmentPaolo A Ascierto, Mariaelena Capone, Walter J Urba, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 16, 2007
Close association between HER-2 amplification and overexpression in human tumors of non-breast originCoya Tapia, Katharina Glatz, Hedvika Novotny, et al.
Histopathology|December 19, 2020
Tumour budding and CD8<sup>+</sup> T cells: 'attackers' and 'defenders' in rectal cancer with and without neoadjuvant chemoradiotherapyNadine D F Georges, Beatrice Oberli, Tilman T Rau, et al.
Cancers|April 13, 2023
Semi-Supervised Learning to Automate Tumor Bud Detection in Cytokeratin-Stained Whole-Slide Images of Colorectal CancerJohn-Melle Bokhorst, Iris D Nagtegaal, Inti Zlobec, et al.
Virchows Archiv : an International Journal of Pathology|January 29, 2017
DNA profiling of tumor buds in colorectal cancer indicates that they have the same mutation profile as the tumor from which they deriveIrene Centeno, Aino Paasinen Sohns, Miriam Flury, et al.
Journal of Translational Medicine|April 1, 2014
CD8/CD45RO T-cell infiltration in endoscopic biopsies of colorectal cancer predicts nodal metastasis and survivalViktor H Koelzer, Alessandro Lugli, Heather Dawson, et al.
Oncotarget|December 22, 2014
TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancerJosé A Galván, Melina Helbling, Viktor H Koelzer, et al.
Scientific Reports|February 21, 2026
CDX2 expression dynamics in tumor clusters: a morpho-molecular biomarker in rectal cancer pretreatment biopsies revealed by sequential immunofluorescenceMauro Gwerder, Cansaran Saygili Demir, Hannah L Williams, et al.
British Journal of Cancer|November 3, 2018
Tumour budding is associated with the mesenchymal colon cancer subtype and RAS/RAF mutations: a study of 1320 colorectal cancers with Consensus Molecular Subgroup (CMS) dataAnne Trinh, Claudia Lädrach, Heather E Dawson, et al.
Pageof 19

Showing results (121-130 of 184) with videos related to

Sort By:
Pageof 19
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
EphB2 expression across 138 human tumor types in a tissue microarray: high levels of expression in gastrointestinal cancersAlessandro Lugli, Hanspeter Spichtin, Robert Maurer, et al.
Journal of Translational Medicine|March 5, 2013
The additional facet of immunoscore: immunoprofiling as a possible predictive tool for cancer treatmentPaolo A Ascierto, Mariaelena Capone, Walter J Urba, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 16, 2007
Close association between HER-2 amplification and overexpression in human tumors of non-breast originCoya Tapia, Katharina Glatz, Hedvika Novotny, et al.
Histopathology|December 19, 2020
Tumour budding and CD8<sup>+</sup> T cells: 'attackers' and 'defenders' in rectal cancer with and without neoadjuvant chemoradiotherapyNadine D F Georges, Beatrice Oberli, Tilman T Rau, et al.
Cancers|April 13, 2023
Semi-Supervised Learning to Automate Tumor Bud Detection in Cytokeratin-Stained Whole-Slide Images of Colorectal CancerJohn-Melle Bokhorst, Iris D Nagtegaal, Inti Zlobec, et al.
Virchows Archiv : an International Journal of Pathology|January 29, 2017
DNA profiling of tumor buds in colorectal cancer indicates that they have the same mutation profile as the tumor from which they deriveIrene Centeno, Aino Paasinen Sohns, Miriam Flury, et al.
Journal of Translational Medicine|April 1, 2014
CD8/CD45RO T-cell infiltration in endoscopic biopsies of colorectal cancer predicts nodal metastasis and survivalViktor H Koelzer, Alessandro Lugli, Heather Dawson, et al.
Oncotarget|December 22, 2014
TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancerJosé A Galván, Melina Helbling, Viktor H Koelzer, et al.
Scientific Reports|February 21, 2026
CDX2 expression dynamics in tumor clusters: a morpho-molecular biomarker in rectal cancer pretreatment biopsies revealed by sequential immunofluorescenceMauro Gwerder, Cansaran Saygili Demir, Hannah L Williams, et al.
British Journal of Cancer|November 3, 2018
Tumour budding is associated with the mesenchymal colon cancer subtype and RAS/RAF mutations: a study of 1320 colorectal cancers with Consensus Molecular Subgroup (CMS) dataAnne Trinh, Claudia Lädrach, Heather E Dawson, et al.
Pageof 19